Executive leadership

Ken Knight , , , President and Chief Executive Officer

Ken leads the Invitae team on its mission to bring genetic information into mainstream medicine to help improve healthcare for billions of people. Before becoming the company's President and CEOKen served as Invitae's chief operating officer from June 2020 to July 2022. Ken is also a member of the board at Invitae. Prior to joining Invitae, he most recently served as vice president of transportation services at Amazon.com, Inc. from December 2019 to June 2020, and as vice president of Amazon's global delivery services and worldwide fulfillment human resources from April 2016 to December 2019. From 2012 to 2016, he served as general manager of the material handling and underground division, a global business with $6 billion in annual revenue, at Caterpillar Inc. In his earlier career, Ken served in various capacities at General Motors Company for 27 years, including as executive director of global manufacturing engineering and as manufacturing general manager. Since June 2021, Ken has served as a director and a member of the audit and finance committee of Simpson Manufacturing Co. Inc. Ken holds a B.S. in Electrical Engineering from the Georgia Institute of Technology and an M.B.A from the Massachusetts Institute of Technology.

Roxi Wen , , , Chief Financial Officer

Roxi leads Invitae’s Finance, Investor Relations, Corporate Development and Transformations teams, helping to scale the business globally by driving growth, capital allocation, financial management and the execution of our unique business model. Roxi also provides oversight to our Patient Network and Data business leveraging her deep experience in technology and innovation. Roxi brings decades of success as a senior business executive where she scaled global technology and medical technology companies. Prior to Invitae, she served as CFO at Mozilla Corporation, overseeing finance, M&A, business development, data and analytics, IT and engineering operations, workplace resources and ESG. Prior to Mozilla, Roxi served in CFO roles at Elo Touch Solutions and General Electric Critical Power following experience driving capital market and business finance efforts at Medtronic, a leading medical technology company. Roxi is a CFA shareholder and has a MBA from the University of Minnesota. 

Desarie French , , , Chief Talent Officer

Desarie leads People & Culture at Invitae in sourcing, recruiting, developing, training and retaining the company’s most valuable asset: our team. Prior to joining Invitae, Desarie served in various human resources leadership roles at Thermo Fisher Scientific, serving multiple functions, businesses and regions with expertise in talent acquisition, M&A and regional leadership roles. Desarie holds a B.A. in Business from Cal Poly, SLO and an M.S. in Employee Relations from Penn State. Desarie has spent most of her career in the healthcare/biotech industry with a passion for building great teams in organizations committed to creating a healthier tomorrow.

Lee Bendekgey , , , Chief Policy Officer

Lee leads Invitae's payer relations, policy and government affairs, regulatory and QA compliance functions, focused on making the company a trusted partner and advocate for patients, healthcare providers, and payers. Previously, Lee has served as both Invitae's chief operating officer and chief financial officer. He has led finance, administrative, and operations functions at public and private genomics and biotechnology companies, including Incyte, Nuvelo, and DNAnexus. Lee earned his B.A. from Kalamazoo College and his law degree from Stanford Law School.

Robert Nussbaum , , M.D. , , Chief Medical Officer

Dr. Nussbaum leads Invitae’s medical team, which is driving forward the science and practice of medical genetics and improving clinical understanding of how to use genetics to improve patient care. Prior to joining Invitae, he was chief of the Division of Genomic Medicine at UCSF Health where he also held leadership roles in the Cancer Genetics and Prevention Program, and the Program in Cardiovascular Genetics, as well as serving as a member of the UCSF Institute for Human Genetics. Earlier, Dr. Nussbaum was chief of the Genetic Disease Research Branch of the National Human Genome Research Institute, one of the National Institutes of Health. He is a member of the National Academy of Medicine and a fellow at the American Academy of Arts and Sciences. Dr. Nussbaum is a board-certified internist and medical geneticist who holds a B.S. in Applied Mathematics from Harvard College and an M.D. from Harvard Medical School in the Harvard-MIT joint program in Health Sciences and Technology. He completed his residency in internal medicine at Barnes-Jewish Hospital and a fellowship in medical genetics at the Baylor College of Medicine.

Tom Brida , , , General Counsel, Chief Compliance Officer and Secretary

Tom leads the legal and compliance team at Invitae. Tom has a broad-based legal background in the life science and diagnostic industries, having advised both public and private multinational companies on transactional and corporate matters. Prior to joining Invitae, Tom served as associate general counsel at Bio-Rad Laboratories and associate in Orrick's corporate and technology group. Tom holds a B.A. from Stanford University and a law degree from U.C. Berkeley School of Law.

Investor Toolkit

Feature Presentation

Email Alerts

Sign up to receive Invitae financial information by email.
Email Address: *

Enter the code shown above.

Investor Contact

1400 16th St.
San Francisco, CA, 94103
Email: ir@invitae.com